Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Molecular aspects of allergens in atopic dermatitis

Molecular aspects of allergens in atopic dermatitis Purpose of reviewMolecular allergology uses pure, mainly recombinant and structurally defined allergen molecules and allergen-derived epitopes to study mechanisms of IgE-associated allergy, to diagnose, and even predict the development of allergic manifestations and to treat and prevent IgE-associated allergies. Atopic dermatitis, a chronic inflammatory skin disease is almost always associated with IgE sensitization to allergens. However, also non-IgE-mediated pathomechanisms seem to be operative in atopic dermatitis and it is often difficult to identify the disease-causing allergens. Here we review recent work showing the usefulness of molecular allergology to study mechanisms of atopic dermatitis, for diagnosis and eventually for treatment and prevention of atopic dermatitis.Recent findingsIgE sensitization to airborne, food-derived, microbial allergens, and autoallergens has been found to be associated with atopic dermatitis. Using defined allergen molecules and non-IgE-reactive allergen derivatives, evidence could be provided for the existence of IgE- and non-IgE-mediated mechanisms of inflammation in atopic dermatitis. Furthermore, effects of epicutaneous allergen administration on systemic allergen-specific immune responses have been studied. Multi-allergen tests containing micro-arrayed allergen molecules have been shown to be useful for the identification of culprit allergens in atopic dermatitis and may improve the management of atopic dermatitis by allergen-specific immunotherapy, allergen avoidance, and IgE-targeting therapies in a personalized medicine approach.SummaryMolecular allergology allows for dissection of the pathomechanisms of atopic dermatitis, provides new forms of allergy diagnosis for identification of disease-causing allergens, and opens the door to new forms of management by allergen-specific and T cells-targeting or IgE-targeting interventions in a personalized medicine approach. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Current Opinion in Allergy and Clinical Immunology Wolters Kluwer Health

Molecular aspects of allergens in atopic dermatitis

Download PDF
9 pages

Loading next page...
 
/lp/wolters-kluwer-health/molecular-aspects-of-allergens-in-atopic-dermatitis-C2Ajp01Oi1

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Wolters Kluwer Health
Copyright
Copyright © 2017 Wolters Kluwer Health, Inc. All rights reserved.
ISSN
1528-4050
eISSN
1473-6322
DOI
10.1097/ACI.0000000000000378
pmid
28622169
Publisher site
See Article on Publisher Site

Abstract

Purpose of reviewMolecular allergology uses pure, mainly recombinant and structurally defined allergen molecules and allergen-derived epitopes to study mechanisms of IgE-associated allergy, to diagnose, and even predict the development of allergic manifestations and to treat and prevent IgE-associated allergies. Atopic dermatitis, a chronic inflammatory skin disease is almost always associated with IgE sensitization to allergens. However, also non-IgE-mediated pathomechanisms seem to be operative in atopic dermatitis and it is often difficult to identify the disease-causing allergens. Here we review recent work showing the usefulness of molecular allergology to study mechanisms of atopic dermatitis, for diagnosis and eventually for treatment and prevention of atopic dermatitis.Recent findingsIgE sensitization to airborne, food-derived, microbial allergens, and autoallergens has been found to be associated with atopic dermatitis. Using defined allergen molecules and non-IgE-reactive allergen derivatives, evidence could be provided for the existence of IgE- and non-IgE-mediated mechanisms of inflammation in atopic dermatitis. Furthermore, effects of epicutaneous allergen administration on systemic allergen-specific immune responses have been studied. Multi-allergen tests containing micro-arrayed allergen molecules have been shown to be useful for the identification of culprit allergens in atopic dermatitis and may improve the management of atopic dermatitis by allergen-specific immunotherapy, allergen avoidance, and IgE-targeting therapies in a personalized medicine approach.SummaryMolecular allergology allows for dissection of the pathomechanisms of atopic dermatitis, provides new forms of allergy diagnosis for identification of disease-causing allergens, and opens the door to new forms of management by allergen-specific and T cells-targeting or IgE-targeting interventions in a personalized medicine approach.

Journal

Current Opinion in Allergy and Clinical Immunology – Wolters Kluwer Health

Published: Aug 1, 2017

References

  • Atopic dermatitis: new evidence on the role of allergic inflammation
  • Cellular and molecular immunologic mechanisms in patients with atopic dermatitis
  • Atopic dermatitis
  • ETFAD/EADV Eczema task force 2015 position paper on diagnosis and treatment of atopic dermatitis in adult and paediatric patients
  • Mechanisms of the development of allergy (MeDALL): introducing novel concepts in allergy phenotypes
  • Immunoglobulin E antibody reactivity to bacterial antigens in atopic dermatitis patients
  • Staphylococcus aureus fibronectin-binding protein specifically binds IgE from patients with atopic dermatitis and requires antigen presentation for cellular immune responses
  • Linking allergy to autoimmune disease
  • Humoral and cellular autoreactivity to epidermal proteins in atopic dermatitis
  • Non-IgE-mediated chronic allergic skin inflammation revealed with rBet v 1 fragments
  • Frequent occurrence of T cell-mediated late reactions revealed by atopy patch testing with hypoallergenic rBet v 1 fragments
  • Efficacy of omalizumab in patients with atopic dermatitis: a systematic review and meta-analysis
  • From allergen genes to allergy vaccines
  • Vaccine development for allergen-specific immunotherapy based on recombinant allergens and synthetic allergen peptides: lessons from the past and novel mechanisms of action for the future
  • Recombinant allergy vaccines based on allergen-derived B cell epitopes
  • Immunoglobulin E-independent major histocompatibility complex-restricted T cell peptide epitope-induced late asthmatic reactions
  • Exacerbation of atopic dermatitis on grass pollen exposure in an environmental challenge chamber
  • Birch pollen-related foods trigger atopic dermatitis in patients with specific cutaneous T-cell responses to birch pollen antigens
  • Association of food allergy and atopic dermatitis exacerbations
  • IgE sensitization profiles differ between adult patients with severe and moderate atopic dermatitis
  • IgE responses to exogenous and endogenous allergens in atopic dermatitis patients under long-term systemic cyclosporine A treatment
  • Alpha-NAC-specific autoreactive CD8+ T cells in atopic dermatitis are of an effector memory type and secrete IL-4 and IFN-gamma
  • Allergen specificity of skin-infiltrating T cells is not restricted to a type-2 cytokine pattern in chronic skin lesions of atopic dermatitis
  • CD8(+) T cells in the lesional skin of atopic dermatitis and psoriasis patients are an important source of IFN-gamma, IL-13, IL-17, and IL-22
  • Skin-infiltrating CD8+ T cells initiate atopic dermatitis lesions
  • Increased Th2 activity and diminished skin barrier function cooperate in allergic skin inflammation
  • Role of B cells as antigen-presenting cells in vivo revisited: antigen-specific B cells are essential for T cell expansion in lymph nodes and for systemic T cell responses to low antigen concentrations
  • Revisiting the role of B cells in skin immune surveillance
  • Heat-labile Escherichia coli toxin enhances the induction of allergen-specific IgG antibodies in epicutaneous patch vaccination
  • High-dose cutaneous exposure to mite allergen induces IgG-mediated protection against anaphylaxis
  • Determinants of efficacy and safety in epicutaneous allergen immunotherapy: summary of three clinical trials
  • Biomarkers for monitoring clinical efficacy of allergen immunotherapy for allergic rhinoconjunctivitis and allergic asthma: an EAACI Position Paper
  • EAACI molecular allergology user's guide
  • Der p 11 is a major allergen for house dust mite-allergic patients suffering from atopic dermatitis
  • Molecular, structural and immunological characterization of Der p 18, a Chitinase-Like house dust mite allergen
  • Different IgE recognition of mite allergen components in asthmatic and nonasthmatic children
  • Real-life study for the diagnosis of house dust mite allergy - the value of recombinant allergen-based ige serology
  • The novel high molecular weight Dermatophagoides farinae protein Zen-1 is a major allergen in North American and European mite allergic dogs with atopic dermatitis
  • The Malassezia genus in skin and systemic diseases
  • The cradle of IgE autoreactivity in atopic eczema lies in early infancy
  • CD8+ T cells are recruited early to allergen exposure sites in atopy patch test reactions in human atopic dermatitis
  • Advances in allergen-microarray technology for diagnosis and monitoring of allergy: the MeDALL allergen-chip
  • Early childhood IgE reactivity to pathogenesis-related class 10 proteins predicts allergic rhinitis in adolescence
  • Sensitization to cat and dog allergen molecules in childhood and prediction of symptoms of cat and dog allergy in adolescence: a BAMSE/MeDALL study
  • Prediction of peanut allergy in adolescence by early childhood storage protein-specific IgE signatures: the BAMSE population-based birth cohort
  • Evolution and predictive value of IgE responses toward a comprehensive panel of house dust mite allergens during the first 2 decades of life
  • Are allergic multimorbidities and IgE polysensitization associated with the persistence or re-occurrence of foetal type 2 signalling? The MeDALL hypothesis
  • Pilot study: assessing the clinical diagnosis of allergy in atopic children using a microarray assay in addition to skin prick testing and serum specific IgE
  • Egg sensitization, allergy and component patterns in African children with atopic dermatitis
  • Microarray-based IgE serology improves management of severe atopic dermatitis in two children
  • How the practice of allergy shows the promise and challenge of personalized medicine
  • Molecular diagnosis and precision medicine in allergy management
  • Personalized medicine in allergy
  • Persistence of IgE-associated allergy and allergen-specific IgE despite CD4+ T cell loss in AIDS
  • Two phase 3 trials of dupilumab versus placebo in atopic dermatitis
  • Anti-IL-5 recombinant humanized monoclonal antibody (mepolizumab) for the treatment of atopic dermatitis
  • Anti-interleukin-31 receptor A antibody for atopic dermatitis
  • Targeting the T helper 2 inflammatory axis in atopic dermatitis
  • Targeting key proximal drivers of type 2 inflammation in disease
  • Improvement of treatment-refractory atopic dermatitis by immunoadsorption: a pilot study
  • IgE-specific immunoadsorption for treatment of recalcitrant atopic dermatitis
  • Repetitive immunoadsorption cycles for treatment of severe atopic dermatitis
  • Panimmunoglobulin and IgE-selective extracorporeal immunoadsorption in patients with severe atopic dermatitis
  • Targeting IgE in severe atopic dermatitis with a combination of immunoadsorption and omalizumab
  • IgE depletion in severe asthma: what we have and what could be added in the near future
  • Extracorporeal IgE immunoadsorption in allergic asthma: safety and efficacy
  • Domestic dog exposure at birth reduces the incidence of atopic dermatitis
  • Dust mite avoidance for the primary prevention of atopic dermatitis: a systematic review and meta-analysis
  • Debates in allergy medicine: specific immunotherapy in children with atopic dermatitis, the ‘con’ view
  • Debates in allergy medicine: specific immunotherapy efficiency in children with atopic dermatitis
  • Specific allergen immunotherapy for the treatment of atopic eczema
  • Allergen-specific immunotherapy with monomeric allergoid in a mouse model of atopic dermatitis
  • Proof of concept of the preventive efficacy of high-dose recombinant mono-allergen immunotherapy in atopic dogs sensitized to the Dermatophagoides farinae allergen Der f 2
  • The future of immunotherapy for canine atopic dermatitis: a review
  • Subcutaneous immunotherapy with a depigmented polymerized birch pollen extract---a new therapeutic option for patients with atopic dermatitis
  • Retrospective analysis on the effects of house dust mite specific immunotherapy for more than 3 years in atopic dermatitis
  • Immunotherapy with the PreS-based grass pollen allergy vaccine BM32 induces antibody responses protecting against hepatitis B infection
  • Development and characterization of a recombinant, hypoallergenic, peptide-based vaccine for grass pollen allergy
  • Skin test evaluation of a novel peptide carrier-based vaccine, BM32, in grass pollen-allergic patients
  • Mechanisms, safety and efficacy of a B cell epitope-based vaccine for immunotherapy of grass pollen allergy
  • Advances in atopic dermatitis
  • IgE: an immunoglobulin specialized in antigen capture?
  • IgE-mediated allergen presentation via Fc epsilon RI on antigen-presenting cells
  • Immunoglobulin E-bearing antigen-presenting cells in atopic dermatitis
  • Blocking antibodies induced by specific allergy vaccination prevent the activation of CD4+ T cells by inhibiting serum-IgE-facilitated allergen presentation
  • Topical skin treatment with Fab fragments of an allergen-specific IgG1 monoclonal antibody suppresses allergen-induced atopic dermatitis-like skin lesions in mice
  • Passive immunization with allergen-specific IgG antibodies for treatment and prevention of allergy
  • Blocking antibodies induced by immunization with a hypoallergenic parvalbumin mutant reduce allergic symptoms in a mouse model of fish allergy
  • Prophylactic and therapeutic vaccination with carrier-bound Bet v 1 peptides lacking allergen-specific T cell epitopes reduces Bet v 1-specific T cell responses via blocking antibodies in a murine model for birch pollen allergy
  • Antibody conjugates bispecific for intercellular adhesion molecule 1 and allergen prevent migration of allergens through respiratory epithelial cell layers